Sorted By:

Relevance


Policy Solutions

PhRMA  |  Policy Paper

Engaging and Empowering Consumers We need to make more information on health care out-of-pocket costs and quality available to patients.
https://www.phrma.org/policy-paper/policy-solutions

Senior Manager – Policy and Research

PhRMA  |  PhRMA Career

Preferred Experience Strong understanding of HHS, Congress and federal health policy process; Experience in federal government or related advocacy environment.
https://www.phrma.org/careers/sr-manager-policy-and-research

Director - IP and Innovation Policy

PhRMA  |  PhRMA Career

The preferred candidate will bring policy development and analytic experience, ideally in a legislative setting, pharmaceutical company or federal agency policy office. 
https://www.phrma.org/careers/director-ip-and-innovation-policy

BIO/PhRMA Principles on Responsible Sharing of Truthful and Non-Misleading Information about Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

In order to support the best use of scientific information for patient care, PhRMA and BIO endorse these Principles on Responsible Sharing of Truthful and Non-Misleading Information About Medicines with Health Care Professionals and Payers.
https://www.phrma.org/codes-and-guidelines/bio/phrma-principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers

Senior Director – State Policy (Mid-Atlantic/Southeast Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-mid-atlantic/southeast-region

Senior Director – State Policy (Pacific Northwest Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-pacific-northwest-region

Senior Director – State Policy (New England Region)

PhRMA  |  PhRMA Career

Preferred Previous experience working in a state government/legislature policy role, national trade association, or the pharmaceutical industry; Advanced degree in Law, Business, Health Policy, Public Policy, or related field.
https://www.phrma.org/careers/senior-director-state-policy-new-england-region

For a Healthier America: PhRMA's Public Policy Strategy to Combat the Opioid Crisis

PhRMA  |  Policy Paper

PhRMA and its members are committed to working with other stakeholders to collectively address this growing public health crisis. Download the document to learn more about the policies we support....
https://www.phrma.org/policy-paper/for-a-healthier-america-phrma-s-public-policy-strategy-to-combat-the-opioid-crisis

Director– Policy and Research

PhRMA  |  PhRMA Career

Pharmaceutical company, congressional/advocacy, and/or policy experience.
https://www.phrma.org

Senior Director – Policy and Research

PhRMA  |  PhRMA Career

The preferred candidate will bring substantive health care policy analysis experience, ideally in a legislative setting, as well as exceptional written and verbal communication skills, the ability to analyze, draft / amend legislative text, expertise in reviewing and interpreting in-depth policy analyses including trend reports and fiscal impact statements, and be focused, organized, detail-oriented, responsive and diplomatic.
https://www.phrma.org

Senior Director - IP and Innovation Policy

PhRMA  |  PhRMA Career

The preferred candidate will bring substantive policy development and analytic experience, ideally in a legislative setting or federal agency policy office.
https://www.phrma.org

Biopharmaceutical Company Communications with Health Care Stakeholders

PhRMA  |  Report

The survey underscores that increased access to more complete information about medicines would help payers make better-informed coverage decisions and allow providers to make better prescribing decisions for patients.
https://www.phrma.org/report/biopharmaceutical-company-communications-with-health-care-stakeholders

Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

PhRMA  |  Blog Post

For example, our estimates suggest that the most pressing policy challenges among the 30+ markets in the BCI Survey in 2017 cost the biopharmaceutical industry up to $148.92 billion in global sales annually – and this may be regarded as a conservative estimate.
http://catalyst.phrma.org/policy-conditions-make-or-break-leaders-in-biopharmaceutical-innovation-preliminary-results-from-the-2017-bci-survey

Privacy Policy

Access Better Coverage  |  From PhRMA

Privacy of our email lists:PhRMA maintains several email lists to keep PhRMA members, the press, and policy makers informed about breaking events.
http://www.accessbettercoverage.org/privacy-policy

PhRMA Prescription Drug Abuse Position Paper

PhRMA  |  Policy Paper

The Pharmaceutical Research and Manufacturers of America (PhRMA) and its members are committed to supporting the appropriate use of prescription medicines and working with others to address the diversion, misuse, and abuse of prescription medicines. When used appropriately and under the direction...
https://www.phrma.org/policy-paper/phrma-prescription-drug-abuse-position-paper

Deputy Vice President – Policy and Research

PhRMA  |  PhRMA Career

The preferred candidate will bring substantive policy development and analytic experience, ideally in a legislative setting or federal agency policy office, as well as exceptional written and verbal communication skills, expertise in reviewing and interpreting in-depth policy analyses including trend reports and fiscal impact statements, and be focused, organized, detail-oriented, responsive and diplomatic. 
https://www.phrma.org

Request for Information: Center for Medicare and Medicaid Services - Innovation Center New Direction

PhRMA  |  Policy Paper

PhRMA is pleased to submitt comments on the Center for Medicare & Medicaid Services (CMS) Request for Information (RFI) on the New Directon for the Innovation Center (CMMI). ...
https://www.phrma.org/policy-paper/request-for-information-center-for-medicare-and-medicaid-services-innovation-center-new-direction

Director – Policy & Research

PhRMA  |  PhRMA Career

Please check our careers page for more opportunities.
https://www.phrma.org/careers/director-policy-and-research

Value-Based Contracting for Oncology Drugs: A NEHI White Paper

PhRMA  |  Report

This white paper from the Network for Excellence in Health Innovation (NEHI) outlines barriers to these outcomes-based contracts and highlights regulatory steps that would enable new payment arrangements for high-cost cancer treatments.  
https://www.phrma.org/report/value-based-contracting-for-oncology-drugs-a-nehi-white-paper

Privacy Policy

PhRMA  |  From PhRMA

While some of these countries may not offer the same level of privacy protection as your own, we commit to uphold the privacy protections as explained in this Policy.
https://www.phrma.org/privacy-policy

PhRMA Comment Letter on CMS Proposed Rule

PhRMA  |  Speeches & Communication

PhRMA comment on [CMS-4182-P] Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.
https://www.phrma.org

PhRMA Comments on Negotiating Objectives for Modernization of NAFTA - June 2017

PhRMA  |  Policy Paper

PhRMA Comments on Negotiating Objectives for Modernization of NAFTA - June 2017...
https://www.phrma.org/policy-paper/phrma-comments-on-negotiating-objectives-for-modernization-of-nafta-june-2017

PhRMA Policy Solutions: Delivering Innovative Treatments to Patients

PhRMA  |  Codes & Guidelines

We are committed to pragmatic, patient-centric approaches to a stronger U.S. health care market, including the biomedical innovation ecosystem. Addressing health care costs holistically, we can build a sustainable, science-based health care system that stems the growth of chronic disease and harn...
https://www.phrma.org

New surveys find payers and providers want more data from biopharmaceutical companies

PhRMA  |  Blog Post

Payers continue to place strong emphasis on FDA approval in their decision-making.
http://catalyst.phrma.org/new-surveys-find-payers-and-providers-want-more-data-from-biopharmaceutical-companies

Strengthening Prescription Drug Monitoring Programs

PhRMA  |  Policy Paper

The Pharmaceutical Research and Manufacturers of America (PhRMA) and its members are committed to supporting the appropriate use of prescription medicines and working with others to prevent and stop diversion and abuse. One of the most promising tools in preventing and detecting potential doctor ...
https://www.phrma.org/policy-paper/strengthening-prescription-drug-monitoring-programs

You have reviewed the first 25 results out of 1102. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next